Substantial clinical benefit values demonstrate a high degree of variability when stratified by time and geographic region.

There may be significant heterogeneity between populations presenting to different institutions, which limits the utility of broadly applying the SCB determined in one patient population as a threshold for clinical success.

also in 13,097 other papers